TY - JOUR
T1 - Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder
AU - Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository
AU - Kremer, Stephane
AU - Renard, Felix
AU - Achard, Sophie
AU - Lana-Peixoto, Marco A.
AU - Palace, Jacqueline
AU - Asgari, Nasrin
AU - Klawiter, Eric C.
AU - Tenembaum, Silvia N.
AU - Banwell, Brenda
AU - Greenberg, Benjamin M.
AU - Bennett, Jeffrey L.
AU - Levy, Michael
AU - Villoslada, Pablo
AU - Saiz, Albert
AU - Fujihara, Kazuo
AU - Chan, Koon Ho
AU - Schippling, Sven
AU - Paul, Friedemann
AU - Kim, Ho Jin
AU - De Seze, Jerome
AU - Wuerfel, Jens T.
AU - Cabre, Philippe
AU - Marignier, Romain
AU - Tedder, Thomas
AU - Van Pelt, Danielle
AU - Broadley, Simon
AU - Chitnis, Tanuja
AU - Wingerchuk, Dean
AU - Pandit, Lekha
AU - Leite, Maria Isabel
AU - Apiwattanakul, Metha
AU - Kleiter, Ingo
AU - Prayoonwiwat, Naraporn
AU - Han, May
AU - Hellwig, Kerstin
AU - Van Herle, Katja
AU - John, Gareth
AU - Hooper, D. Craig
AU - Nakashima, Ichiro
AU - Sato, Douglas
AU - Yeaman, Michael R.
AU - Waubant, Emmanuelle
AU - Zamvil, Scott
AU - Stüve, Olaf
AU - Aktas, Orhan
AU - Smith, Terry J.
AU - Jacob, Anu
AU - O'Connor, Kevin
N1 - Publisher Copyright:
Copyright 2015 American Medical Association. All rights reserved.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Brain parenchymal lesions are frequently observed on conventional magnetic resonance imaging (MRI) scans of patients with neuromyelitis optica (NMO) spectrum disorder, but the specific morphological and temporal patterns distinguishing them unequivocally from lesions caused by other disorders have not been identified. This literature review summarizes the literature on advanced quantitative imaging measures reported for patients with NMO spectrum disorder, including proton MR spectroscopy, diffusion tensor imaging, magnetization transfer imaging, quantitative MR volumetry, and ultrahigh-field strength MRI. It was undertaken to consider the advanced MRI techniques used for patients with NMO by different specialists in the field. Although quantitative measures such as proton MR spectroscopy or magnetization transfer imaging have not reproducibly revealed diffuse brain injury, preliminary data from diffusion-weighted imaging and brain tissue volumetry indicate greater white matter than gray matter degradation. These findings could be confirmed by ultrahigh-field MRI. The use of nonconventional MRI techniques may further our understanding of the pathogenic processes in NMO spectrum disorders and may help us identify the distinct radiographic features corresponding to specific phenotypic manifestations of this disease.
AB - Brain parenchymal lesions are frequently observed on conventional magnetic resonance imaging (MRI) scans of patients with neuromyelitis optica (NMO) spectrum disorder, but the specific morphological and temporal patterns distinguishing them unequivocally from lesions caused by other disorders have not been identified. This literature review summarizes the literature on advanced quantitative imaging measures reported for patients with NMO spectrum disorder, including proton MR spectroscopy, diffusion tensor imaging, magnetization transfer imaging, quantitative MR volumetry, and ultrahigh-field strength MRI. It was undertaken to consider the advanced MRI techniques used for patients with NMO by different specialists in the field. Although quantitative measures such as proton MR spectroscopy or magnetization transfer imaging have not reproducibly revealed diffuse brain injury, preliminary data from diffusion-weighted imaging and brain tissue volumetry indicate greater white matter than gray matter degradation. These findings could be confirmed by ultrahigh-field MRI. The use of nonconventional MRI techniques may further our understanding of the pathogenic processes in NMO spectrum disorders and may help us identify the distinct radiographic features corresponding to specific phenotypic manifestations of this disease.
UR - http://www.scopus.com/inward/record.url?scp=84937548674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937548674&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2015.0248
DO - 10.1001/jamaneurol.2015.0248
M3 - Review article
AN - SCOPUS:84937548674
SN - 2168-6149
VL - 72
SP - 815
EP - 822
JO - JAMA Neurology
JF - JAMA Neurology
IS - 7
ER -